EL
IMNM icon

EMFO LLC’s Immunome IMNM Stock Holding History

EMFO LLC’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$143K Hold
11,835
– – 0.13% 109
2024
Q1 		$292K Sell
11,835
-47,330
-80% -$960K 0.27% 76
2023
Q4 		$633K Buy
+59,165
New +$492K 0.58% 45

Other funds holding IMNM

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EMFO LLC's IMNM Position: Q2 2024 in Review

EMFO LLC held its Immunome (IMNM) position steady in Q2 2024 at 11,835 shares worth $143K. The position accounts for 0.13% of the portfolio, ranked #109.

EMFO LLC first reported a position in IMNM in Q4 2023 and has held it in 3 quarters since. The position peaked at $633K in Q4 2023. 113 funds tracked by Wall St. Rank hold IMNM as of Q2 2024.

  • EMFO LLC held 11,835 shares of Immunome worth $143K as of Q2 2024.
  • EMFO LLC left its Immunome share count unchanged in Q2 2024.
  • Immunome made up 0.13% of EMFO LLC's portfolio in Q2 2024, its #109 holding.
  • EMFO LLC first reported a position in Immunome in Q4 2023 and has held it in 3 quarters since.
  • EMFO LLC's Immunome position peaked at $633K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Immunome as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.